Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley A Mathews

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Scientific Reports|April 2, 2020
Identification of Small Molecule Enhancers of Immunotherapy for MelanomaChristopher Dextras, Myagmarjav Dashnyam, Lesley A Mathews Griner, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2015
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemiaMeili Zhang, Lesley A Mathews Griner, Wei Ju, et al.
Molecular Cancer Therapeutics|August 10, 2019
Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like PhenotypeYansong Bian, Yaroslav Teper, Lesley A Mathews Griner, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Cancer Cell|June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaYibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular DystrophyApurva Sarathy, Ryan D Wuebbles, Tatiana M Fontelonga, et al.
Scientific Reports|September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsBryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Cancer Research|January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAFWenlin Shao, Yuji M Mishina, Yun Feng, et al.
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Journal of Medicinal Chemistry|June 13, 2022
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward MetastasisKevin J Frankowski, Samarjit Patnaik, Chen Wang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Scientific Reports|April 2, 2020
Identification of Small Molecule Enhancers of Immunotherapy for MelanomaChristopher Dextras, Myagmarjav Dashnyam, Lesley A Mathews Griner, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2015
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemiaMeili Zhang, Lesley A Mathews Griner, Wei Ju, et al.
Molecular Cancer Therapeutics|August 10, 2019
Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like PhenotypeYansong Bian, Yaroslav Teper, Lesley A Mathews Griner, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Cancer Cell|June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaYibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular DystrophyApurva Sarathy, Ryan D Wuebbles, Tatiana M Fontelonga, et al.
Scientific Reports|September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsBryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Cancer Research|January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAFWenlin Shao, Yuji M Mishina, Yun Feng, et al.
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Journal of Medicinal Chemistry|June 13, 2022
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward MetastasisKevin J Frankowski, Samarjit Patnaik, Chen Wang, et al.
Pageof 4